BAY 3713372 Bayer, BAY 3713372 Bayer, -, -, -, -
Phase 2 small_molecule active
Quick answer
BAY 3713372 Bayer, BAY 3713372 Bayer, -, -, -, - for MTAP-deleted Solid Tumors is a Phase 2 program (small_molecule) at Bayer AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bayer AG
- Indication
- MTAP-deleted Solid Tumors
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active